Renee D Gala - Director, Corcept Therapeutics Inc

As of August 22, 2018


Renee D Gala Net Worth

  • Net worth is estimated to be at least $5.66M
  • Owns at least 10,000 units of Corcept Therapeutics Inc stock

Renee D Gala Trading

  • Largest purchase of shares was 10,000 units , worth over $155.1K on March 7, 2018
  • In total has made about 4 transactions over 2 years
  • Usually trades in June, August, May and March, with the busiest year in 2018
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Renee D Gala Mailing Address

  • Mailing address is 901 Gateway Blvd South San Francisco CA 94080 CA

Corcept Therapeutics Inc Executive Compensation

Name
Year
Salary
Bonus
Option Awards
Other Compensation
Total
Joseph K. Belanoff, M.D., 2020 $769,567 $744,000 $4,237,643 $10,892 $5,762,102
Joseph K. Belanoff, M.D., 2019 $707,525 $745,290 $3,506,155 $ $4,958,970
Joseph K. Belanoff, M.D., 2018 $679,792 $477,750 $5,157,075 $ $6,314,617
Andreas Grauer, M.D., 2020 $454,550 $219,157 $1,271,293 $118,274 $2,063,274
Andreas Grauer, M.D., 2019 $362,267 $243,720 $3,115,335 $78,245 $3,799,567
Hazel Hunt, Ph.D., 2020 $431,873 $243,000 $2,084,640 $ $2,759,513
Sean Maduck, 2020 $474,380 $214,157 $2,508,404 $ $3,196,941
Sean Maduck, 2019 $456,133 $308,881 $1,476,276 $ $2,241,290
Sean Maduck, 2018 $436,667 $198,000 $2,171,400 $ $2,806,067
Charles Robb, 2020 $474,380 $321,236 $2,118,822 $ $2,914,438
Charles Robb, 2019 $456,133 $308,881 $1,845,345 $ $2,610,359
Charles Robb, 2018 $436,667 $237,600 $2,171,400 $ $2,845,667
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1088856/000162828021007363/a2021def14a.htm

Corcept Therapeutics Inc Insider Trading

  • The most recent transaction was 25,000 units sold on October 5, 2021 by Sean Maduck worth over $500.11K
  • In the last 17 years, insiders at Corcept Therapeutics Inc sold an estimated value of $161.71M and bought an estimated value of $183.35M
  • The most active traders are Joseph K., Chief Executive Officer,  Robert Roe, President and Secretary,  and Leonard Baker Jr, Director
  • Insider trading is most common in February, with the busiest year in 2006

CORCEPT THERAPEUTICS INC Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1